Clinical trial
Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism
NCT00848731 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- May 31, 2011
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.